Clinical Trial Update: Safety Study of Once-a-Day Dosing of Udenafil to Treat Erectile Dysfunction [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 safety study evaluating once-daily udenafil for erectile dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• udenafil (udenafil)

Snippet

Sponsor: Dong-A Pharmaceutical Co., Ltd. | Conditions: Erectile Dysfunction | Phase 3 | Status: COMPLETED